Product News

EMA Adopts Positive Opinion of RLS Treatment Targin

European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Targin. By Mundipharma, Targin is a fixed combination of prolonged-release oxycodone/naloxone, and is a second-line symptomatic treatment of patients with severe to very severe idiopathic restless legs syndrome (RLS), after failure of dopaminergic therapy.

Industry News

Dental Sleep Solutions Partners with GoGo Billing

Dental Sleep Solutions, which offers end-to-end implementation solutions for dental practices via its flagship product DS3 Software, has entered a partnership with GoGo Billing, which manages billing services for DSM, TMD, and other medically necessary dental treatments.

Case Reports

Sleep Difficulties Common Among Toddlers with Psychiatric Disorders

John Boekamp, PhD, clinical director of the Pediatric Partial Hospital Program (PPHP) at Bradley Hospital, recently led a study that found sleep difficulties—particularly problems with falling asleep—were very common among toddlers and preschool-aged children who were receiving clinical treatment for a wide range of psychiatric disorders.